BMD
10
2
2
5
Key Insights
Highlights
Success Rate
83% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
10.0%
1 terminated out of 10 trials
83.3%
-3.2% vs benchmark
20%
2 trials in Phase 3/4
0%
0 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (10)
Swiss Registry for Neuromuscular Disorders
SGLT2 Inhibitors Between Reno Protective Effects and Impact on Bone and Mineral Disease Among Lupus Nephritis Patients
Defining Outcome Measures for Behavioural and Emotional Problems in Dystrophinopathies
Nutrition Status, BMD, and SSRIs
Doravirine and Weight Gain in Antiretroviral Naive
The Effect of Weight Loss on Bone in Men
Body Mass Index and Obesity Surgery Mortality Risk Score in Perioperative Complications of Laparoscopic Sleeve Gastrectomy
Bone Mineral Density, Disease Duration, and Activity in Ankylosing Spondylitis
Vitamin D Levels in Adolescent Idiopathic Scoliosis
The Effect of High Impact Exercise on Bone and Articular Cartilage in Post-menopausal Women